| Literature DB >> 34912236 |
Xiquan Weng1, Jieru Lin1, Yu Yuan1, Baoxuan Lin2, Weiwei Huang3, Hiu Tung Tin4, Jia Li4, Xu Yan4,5, Wentao Lin1, Hao Chen1.
Abstract
In prolonged intense exercise training, the training load of athletes may be reduced once their hemoglobin concentrations ([Hb]s) are decreased dramatically. We previously reported that intermittent hypoxia exposure (IHE) could be used to alleviate the decrease of [Hb] and help to maintain the training load in rats. To further explore the feasibility of applying IHE intervention to athletes during prolonged intense exercise training, 6 trained swimmers were recruited to conduct a 4-week IHE intervention at the intervals after their [Hb] dropped for 10% or more during their training season. IHE intervention lasted 1 h and took place once a day and five times a week. Hematological and hormonal parameters, including [Hb], red blood cells (RBC), hematocrit (Hct), reticulocytes, serum erythropoietin (EPO), testosterone (T) and cortisol (C) were examined. After the IHE intervention was launched, [Hb], RBC and Hct of the subjects were increased progressively with their maximum levels (P < 0.01) showing at the third or fourth week, respectively. An increase in reticulocyte count (P < 0.01) suggests that IHE intervention promotes erythropoiesis to increase [Hb]. Besides, serum level of EPO, the hormone known to stimulate erythropoiesis, was overall higher than that before the IHE intervention, although it was statistically insignificant. Furthermore, the serum level of T, another hormone known to stimulate erythropoiesis, was increased progressively with the maximum level showing at the fourth week. Collectively, this study further confirms that IHE intervention may be used as a new strategy to prevent intense exercise training-induced reductions in [Hb].Entities:
Keywords: EPO; IHE; erythropoietin; hemoglobin; hypoxia; testosterone
Year: 2021 PMID: 34912236 PMCID: PMC8667786 DOI: 10.3389/fphys.2021.736108
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
FIGURE 1The hematological parameters of the subjects in various weeks. (A) Hemoglobin (Hb); (B) red blood cells (RBCs); (C) hematocrit (Hct) levels. ∗Significantly different from week 0, P < 0.05.
Some hematological parameters of subjects during IHE intervention.
|
|
|
|
|
|
|
|
| Week 0 | 76.98 ± 7.83 | 12.78 ± 0.79 | 38.10 ± 1.49 | 2.66 ± 0.16 | 29.30 ± 3.85 | 28.53 ± 3.65 |
| Week 1 | 77.10 ± 7.35 | 12.78 ± 0.67 | 37.98 ± 2.13 | 2.59 ± 0.09 | 29.28 ± 4.17 | 28.63 ± 3.91 |
| Week 2 | 77.20 ± 7.94 | 12.85 ± 0.75 | 38.38 ± 1.38 | 2.65 ± 0.13 | 29.60 ± 3.91 | 28.85 ± 3.63 |
| Week 3 | 78.13 ± 8.06 | 12.81 ± 0.73 | 38.08 ± 1.45 | 2.64 ± 0.15 | 29.68 ± 3.96 | 28.73 ± 3.72 |
| Week 4 | 77.81 ± 8.01 | 12.78 ± 0.66 | 38.11 ± 1.45 | 2.63 ± 0.14 | 29.65 ± 3.93 | 28.65 ± 3.67 |
The Retic# and Retic% of subjects during IHE intervention.
|
|
|
|
| Week 0 | 50.23 ± 6.84 | 0.99 ± 0.15 |
| Week 1 | 60.75 ± 15.09 | 1.20 ± 0.29 |
| Week 2 | 66.13 ± 12.96 | 1.28 ± 0.31 |
| Week 3 | 63.53 ± 13.23 | 1.25 ± 0.28 |
| Week 4 | 65.81 ± 12.26 | 1.27 ± 0.26 |
*Significantly different from week 0,
FIGURE 2The hormonal parameters of the subjects in various weeks. (A) Serum erythropoietin (EPO) levels; (B) serum T levels; (C) serum C levels; (D) serum T/C levels. ∗Significantly different from week 0, P < 0.05.